As of August 28, 2026, China Pharma Holdings, Inc. (CPHI) has a DilutionWatch DilutionScore of 68/100, rated HIGH dilution risk. China Pharma Holdings, Inc. has a market capitalization of $32.16M, 43.02M shares outstanding.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
⛈️
Warning
High probability of dilution event
model est. 64%
🔄 Reverse Split
model est. 70%
• 50-day avg $0.66 below $1 exchange minimum
• Only 2 months cash — financial pressure
🔁 Convertible Conversion
model 60%
• Major convertible overhang: 39% potential dilution
• Convertible risk score very high (85/100)
💰 Capital Raise
model 55%
• Critical: only 1.7 months cash remaining
Market Data
Market Cap$32.16M
Shares Outstanding43.02M
Float37.84M
Cash$304.9K
Debt$5.98M
Short InterestN/A
Institutional Holdings
0.1% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
Short Interest
Short Interest115.7K
Days to Cover1.0
% of Float0.3%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL CONVERTIBLE
2024-12-31
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual CPHI Dilution Snapshot
China Pharma Holdings, Inc. (CPHI) has a DilutionScore of 68/100, rated High dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for CPHI: xbrl on 2024-12-31.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track CPHI Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CPHI — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for CPHI
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.